Manuscript
High p95HER2/HER2 ratio associated with poor outcome in Trastuzumab-treated HER2-positive metastatic breast cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)
March 1, 2018
Find Locations
For hours, walk-ins and appointments.